this study would enroll 600 HBsAg positive mothers, including 240 cases with high serum HBV DNA load during pregnancy, 120 cases treated with antiviral therapy for hepatitis B, 120 cases with HBV DNA negative during pregnancy, 120 cases with high serum HBV DNA but receive antiviral therapy in late of pregnancy, and all of their infants.